Day clinic and inpatient psychotherapy of depression – a randomized controlled pilot study

Not Applicable

• Conditions: F32; F33; F34.1; Depressive episode; Recurrent depressive disorder; Dysthymia

• Registration Number: DRKS00000550
• Lead Sponsor: niversitätsklinikum Heidelberg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2010-11-25
• Study Completion: 2012-12-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 44

Inclusion Criteria

Depressive Disorder (F32, F33, or F34.1) and place of residence within 80 km around Heidelberg

Exclusion Criteria

psychotic and bipolar disorder,
currently manifest addictive disorder,
Borderline Personality Disorder,
Anorexia nervosa,
Bulimia nervosa and Binge Eating Disorder with > 3 binges/day,
planned treatment duration < 4 weeks

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary Outcome of the study are depressive symptoms 3 months after termination of therapy. The primary outcome will be rated by trained observes with the Hamilton Ratings Scale of Depression (HAM-D).

Secondary Outcome Measures

Name	Time	Method
Secondary outcome is the number and intensity of depressive symptoms from the patients' view. This is assessed at termination of therapy as well as 3 months after termination with the Beck Depression Inventory (BDI).<br>An additional secondary outcome is the number and intensity of global psychological symptoms from the patients perspective. This is assessed at termination of therapy as well as 3 months after termination with the revised Symptom Checklist 90 (SCL-90-R).